Evidence Review — Bengaluru
Medically reviewed by Dr. Chetan M. Dojode, FRCS (Tr & Orth), Consultant Orthopaedic Surgeon · Last reviewed 20 July 2026
Dr. Chetan M. Dojode · FRCS (Orth, UK) · FEBOT (Euro) · MRCS (UK) · MCh (Orth, UK) · MS (Orth) · MBBS · GMC Specialist Register
21+ Years Experience · 11+ Years NHS UK · MAKO Robotic Certified
What is established, what is still unproven, and who benefits most
Patients seen from across Bengaluru, Karnataka and overseas
Robotic joint replacement is marketed heavily, and the marketing has run some distance ahead of the evidence. This page is written to set out what the published literature actually supports, what it does not yet support, and where robotic assistance is most likely to be worth the additional cost. It includes the parts that are inconvenient to the argument for robotics.
The reason for writing it this way is straightforward. Patients considering a joint replacement are making a decision they will live with for decades, often paying privately for the robotic component. They are entitled to know which claims rest on good evidence and which rest on plausibility and enthusiasm.
First, what the technology actually does. In MAKO robotic-assisted replacement, a CT scan taken before surgery is used to build a three-dimensional model of the joint. The operation is planned on that model — implant size, position, alignment and the resulting soft-tissue balance. In theatre, the surgeon executes that plan while the robotic arm provides a haptic boundary, resisting movement of the cutting instrument outside the planned envelope. The plan can be adjusted intra-operatively as the surgeon assesses the ligaments through range.
What it does not do is operate. The robot makes no decisions, holds no opinions about your knee, and cannot compensate for a poor plan. It is an instrument for delivering a plan accurately. A well-planned operation executed accurately is better than a well-planned operation executed approximately — but a poorly planned operation executed accurately is simply a poor operation performed precisely.
The most persuasive evidence for robotic assistance is not in routine total knee replacement but in partial (unicompartmental) knee replacement. Partial replacement is technically less forgiving — the margin for error in component position is smaller, and historically its revision rate has been higher than that of total replacement. Registry and comparative data have shown improved survivorship for robotically assisted partial knee replacement relative to conventional technique. There is a coherent reason for this: where accuracy matters most, an instrument that improves accuracy contributes most. The same logic applies to acetabular cup positioning in hip replacement, where malposition is a known cause of wear, impingement and dislocation.
In a straightforward total knee replacement performed by an experienced surgeon on a knee without significant deformity, the demonstrated benefit of robotic assistance is modest. Randomised trials consistently show better radiographic alignment, but the translation of that into patient-reported outcome scores at one and two years has generally been small and often below the threshold patients would notice. Long-term survivorship data comparing robotic and conventional total knee replacement is still maturing; the technology has not been in widespread use long enough for definitive answers. Anyone claiming that robotic total knee replacement is proven to last longer is stating something the literature does not currently support.
Robotic assistance adds cost, and that cost is generally borne by the patient. It requires a pre-operative CT scan, which involves a radiation dose that conventional planning does not. It adds operating time, particularly during a surgeon’s learning curve, and outcomes during that learning period are not the same as those in established practice. The technology is also implant-linked: the robot works with specific implant systems, which constrains implant choice to what the platform supports. None of these are reasons to avoid robotic surgery. They are reasons to ask whether it adds enough in your particular case to justify what it costs.
Dr. Chetan M. Dojode has operated in both the United Kingdom and India. His UK joint replacement practice is recorded on the National Joint Registry (NJR) — the world’s largest independent registry of joint replacement outcomes, which tracks implant survival and revision rates for every procedure submitted. Registries of this kind are precisely the mechanism by which the long-term value of robotic assistance will eventually be settled, one way or the other.
Not for total knee replacement. Randomised evidence shows robotic assistance improves component alignment and reduces outliers, but long-term survivorship data comparing robotic and conventional total knee replacement is still maturing and does not yet demonstrate longer implant life. The evidence is stronger for robotic partial knee replacement, where registry data has shown improved survivorship relative to conventional technique.
Trials consistently show better radiographic alignment with robotic assistance. Translation into patient-reported function at one to two years has generally been small, and often below the level a patient would notice. Several studies report less early post-operative pain and faster initial recovery. The honest position is that alignment benefit is established while long-term functional superiority is not.
Patients undergoing partial knee replacement, those with significant deformity or complex anatomy, patients with previous fractures or retained metalwork, and hip replacements where cup position and leg length restoration are demanding. In a straightforward knee replacement in a well-aligned knee, the demonstrated additional benefit is modest.
No. The surgeon plans the operation, performs it, and remains responsible for every decision. The robotic arm provides a haptic boundary that resists movement outside the planned envelope, and the surgeon can adjust the plan at any point during the operation. The technology delivers a plan; it does not create one.
That depends on your case. Where accuracy tolerances are tight — partial knee replacement, significant deformity, complex hip anatomy — the case is reasonably strong. For a straightforward replacement in a well-aligned joint performed by an experienced surgeon, the additional demonstrated benefit is smaller and the decision is more finely balanced. You should expect a clear answer about which category you fall into rather than a general recommendation.
CT-based systems such as MAKO require a pre-operative CT scan, which carries a radiation dose that conventional planning does not. The dose is modest and protocols are optimised to limit it, but it is a genuine additional exposure and worth knowing about, particularly in younger patients.
Dr. Chetan M. Dojode
FRCS (Tr&Orth) UK · FEBOT
GMC Specialist Register
OSR — OrthoSportsRobotics Clinic / Aarna Clinic, Sahakar Nagar
1182/1, 20th Main Road, A Block,
Bengaluru 560092
UK-trained FRCS orthopaedic surgeon — Sparsh Hospital Yelahanka & OSR — OrthoSportsRobotics Clinic / Aarna Clinic Sahakar Nagar